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Abstract 
 
Electron transfer from a biotinylated electron donor to photochemically generated Ru(III) complexes covalently 
anchored to streptavidin is demonstrated by means of time-resolved laser spectroscopy. Through site-selective 
mutagenesis, a single cysteine residue was engineered at four different positions on streptavidin, and a Ru(II) tris-
diimine complex was then bioconjugated to the exposed cysteines. A biotinylated triarylamine electron donor was 
added to the Ru(II)-modified streptavidins to afford dyads localized within a streptavidin host. The resulting systems 
were subjected to electron transfer studies. In some of the explored mutants, the phototriggered electron transfer 
between triarylamine and Ru(III) is complete within 10 ns, thus highlighting the potential of such artificial 
metalloenzymes to perform photoredox catalysis. 
 
Introduction 
 
Streptavidin (hereafter Sav) is an exquisitely robust protein of ca. 64 kDa comprised of four homologous sub-units, 
each of which can bind a biotin molecule with an association constant of 1014 M-1 under physiological conditions.1 
Sav can readily be over-expressed and purified from the bacterium Escherichia coli. Owing to this combination of 
favorable properties, biotin-streptavidin systems have been exploited in various contexts where host-guest 
recognition is desirable, ranging from targeted drug delivery, to live cell imaging and new applications in catalysis.2  
By biotinylation of small metal catalysts, novel catalytic functions can be conferred to the resulting biotin-
streptavidin assemblies, resulting in artificial metalloenzymes.3 Their function can be tailored either chemically, i. e., 
through variation of the biotin-linker-catalyst moiety, or genetically through site-specific mutagenesis of Sav. In the 
best case, such chemogenetic optimization can lead to catalytic performance which is superior to that observed for 
the related small metal catalyst outside the protected environment of the biotin binding pockets of Sav, manifesting 
for example in unusually high enantioselectivity.4  
In principle, such artificial metalloenzymes should also be amenable to the emerging field of redox photocatalysis,5 
and for this purpose it would be desirable to equip the biotin-streptavidin systems with redox photosensitizers. 
Complexes of d6 metal ions such as ruthenium(II) and iridium(III) are good candidates in this regard.  
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There have been several studies of the luminescence properties of biotinylated d6 metal complexes, including 
ruthenium(II) polypyridines,6 rhenium(I) tricarbonyl diimines,7 and cyclometalated iridium(III) complexes.8 In most 
cases, binding to streptavidin leads to enhanced luminescence properties, and this is important for example for cell 
imaging purposes.9 The above mentioned classes of metal complexes are well suited for photosensitization of 
electron transfer reactions,10 but, to the best of our knowledge, this has not yet been realized within the context of 
the biotin-streptavidin technology.11 However, ruthenium(II) and rhenium(I) complexes have been employed 
frequently for investigation of phototriggered electron-transfer in other proteins (e. g., azurin, cytochrome c, or 
plastocyanin), mostly for distance-dependence studies and for elucidating electron tunneling pathways.12 The 
ruthenium(II) and rhenium(I) metal centers were commonly ligated to histidine ligands for this purpose, and the 
natural redox-active groups of these proteins (e. g., blue copper centers or heme groups) served as electron-transfer 
reaction partners. 
Typical photoredox systems usually require a photosensitizer combined with a distinct catalytic moiety. As the 
binding of biotinylated probes to Sav is non-cooperative, introducing two distinct dyads within a streptavidin 
tetramer remains an unmet challenge.13 To assemble such dyads using a Sav scaffold, we thus opted to bioconjugate 
the photosensitizer to an engineered cysteine residue, thus leaving the four biotin-binding sites of Sav free to 
introduce either a catalytic or an electron-donor moiety. 
As Sav possesses no cysteine residue, site-directed mutagenesis was used to engineer this highly nucleophilic residue 
at selected positions. The resulting single-point mutants were subsequently bioconjugated with a [Ru(bpy)2(phen)]
2+-
photosensitizer 1 (Figure 1, bpy = 2,2’-bipyridine, phen = 1,10-phenanthroline). The triarylamine (TAA) unit was 
equipped with a biotin group to yield Biot-TAA (see SI for details, 2 displayed in Figure 1). The resulting Biot-TAA / 
Ru(II)-streptavidin adducts are donor-acceptor systems in which phototriggered electron transfer can be 
investigated. The goal of this work was to explore whether phototriggered electron injection from a biotinylated 
donor to ruthenium(II)-labeled streptavidin is possible and if so, what position on the surface of Sav is most suitable 
for the covalent anchoring of the photosensitizer.  
 
Results and discussion 
 
Structural and synthetic aspects. The ruthenium(II) complex (rac-1 displayed in Figure 1) was covalently tethered to 
streptavidin through nucleophilic attack by a cysteine residue with concomitant elimination of HBr.14 Single cysteine 
residues were introduced by site directed mutagenesis on each of the four homologous units of streptavidin, leading 
to a fourfold Ru(II)-labeling of each streptavidin tetramer. The biotinylated triarylamine unit Biot-TAA was 
synthesized as a binding partner. The acetyl-substituted triarylamine (TAA-Ac) 3 served as a reference compound 
(Figure 1). Syntheses and mutagenesis procedures are presented in the Supporting Information. 
Inspection of the X-ray structure of S112A Sav (pdb code: 3PK2)15 led us to select four positions for the introduction 
of a cysteine residue by site-directed mutagenesis. The following four mutants were produced using a previously 
published method and purified by affinity chromatography16 and characterized by ESI-MS: Sav T66C, R84C, S112C, 
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and K121C (Figure 2). Subsequent bioconjugation was achieved by mixing the mutant protein overnight with an 
eightfold excess of Ru-complex 1 at 4°C in phosphate buffer (50 mM, pH 7) in the dark. The excess of the unbound 
Ru-complex 1 was removed by dialysis and the resulting Ru4Sav bioconjugates (Ru4Sav T66C, Ru4Sav R84C, Ru4Sav 
S112C, and Ru4Sav K121C respectively) were characterized by ESI-MS, revealing a quantitative conversion to the Ru-
containing proteins (See SI for details). The biotin-binding capacity of the Ru4Sav bioconjugates was assessed relying 
on a displacement titration using HABA (2-(4-hydroxyphenylazo)benzoic acid). Upon incorporation within Sav, HABA 
displays an absorption at max 506 nm. Upon addition of biotinylated probes, the HABA is displaced, leading to a 
disappearance of the absorption at 506 nm.4a, 17 This simple procedure revealed that all four biotin-binding sites can 
accommodate the biotinylated cofactor Biot-TAA, and the affinity is similar to that of pure unmodified biotin (see 
Figure3, more details in the Supporting Information). This confirms that the bulky Biot-TAA moieties bind to Ru4Sav 
isoforms, despite the presence of the bulky Ru(bpy)2(phenNHCOCH2) moieties which, in the S112C and K121C 
mutants, lie in the proximity of the biotin-binding vestibule. 
 
Since no crystal structure could be obtained so far, through-space distances were estimated based on a previously 
published crystal structure of an Ir-loaded streptavidin mutant (pdb code: 3PK2).15 The arylated biotin moiety 
bearing a para-sulfur atom was used for distance estimation. This latter sulfur atom was selected as a surrogate for 
the nitrogen atom of the Biot-TAA moiety (Figure S16). The shortest through-space distances from the sulfur atom 
to the -carbon of the amino acids targeted for mutagenesis ranges from 7.1 to 22.1 Å (Table 1). As, by symmetry 
four cysteine residues result from a single point mutation, the mean value of the two closest residues was also 
determined: it increases from K121 (7.9 Å) < S112 (9.5 Å) < R84 (18.3 Å) < T66 (20.0 Å) . 
 
Electron transfer studies. To explore the electron transfer in the Biot-TAA / Ru(II)-streptavidin dyads a flash quench 
technique was applied (Figure 4).18 Therefore, the ruthenium(II) photosensitizer was excited selectively at 532 nm 
with laser pulses of 10 ns duration. In the presence of 120 mM methylviologen dichloride (MV2+) added to the 
aqueous solution, the luminescent 3MLCT excited state of the photosensitizer *Ru(II) is quenched oxidatively with 
diffusion-limited kinetics, i. e., initial excitation (“flash”) is followed by oxidation of *Ru(II) to Ru(III) (“quench”) 
within the 10 ns duration of the laser pulse. 
In a sample containing 50 M Ru(II)-streptavidin (K121C mutant) and 120 mM MV2+ but no Biot-TAA in MilliQ water 
at 25 °C, one observes the typical spectroscopic signatures of the MV●+ radical (green trace in Figure 5a).19 
Specifically, there is a sharp and intense absorption at 393 nm and a broader, less intense band with a maximum at 
605 nm which can be attributed unambiguously to MV●+.19-20 The oxidation product Ru(III) manifests as a bleach at 
450 nm. When adding 25M Biot-TAA to the same solution, an additional band at 760 nm becomes observable 
(black trace in Figure 5a) in addition to the MV●+ bands. The band at 760 nm is typical for TAA+,21 and hence this is 
clear evidence for electron transfer from TAA to Ru(III), which (based on the relevant redox potentials)21 is expected 
to be associated with a reaction free energy (GET
0) of ca. -0.5 eV. In the reference experiment in which 50M Ru(II)-
streptavidin and 120 mM MV2+ were measured in the presence of 25M TAA-Ac, the band at 760 nm does not 
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appear (blue trace in Figure 5a), confirming that in the Ru(II)-streptavidin (K121C mutant) / TAA-biotin system, the 
phototriggered electron transfer from TAA to Ru(III) does indeed rely on the tight association between the 
streptavidin host and the Biot-TAA guest. 
The TAA+ signal at 760 nm rises with instrumentally limited kinetics (black trace in Figure 5b), indicating that 
phototriggered electron transfer from TAA-biotin to Ru(III)-streptavidin (K121C mutant) occurs with a rate constant 
kET ≥ 10
8 s-1. The signal then decays on a timescale > 10 s, due to bimolecular electron transfer between Biot-TAA+ 
and MV●+ (Figure 5b). MV●+ has non-negligible absorbance at 760 nm hence the observation of small signals even in 
absence of Biot-TAA (blue and green traces in Figure 5b). 
For the S112C mutant, qualitatively similar results are obtained (Supporting Information). There is clear indication 
for rapid (kET ≥ 10
8 s-1) electron transfer from Biot-TAA to Ru(III)-streptavidin, and the resulting photoproduct is again 
very long-lived (> 10 s). However, for the R84C and T66C mutants, no such evidence was obtained. We conclude 
that these two ruthenium(II)-labeled mutants are not well suited for electron transfer with biotinylated triarylamine 
guests. This findings correlate with the increasing distances between the photosensitizer and the electron donating 
triarylamine. It is possible that electron transfer between photoexcited Ru(II) and MV2+ is less efficient in these cases 
even though they seem to be even better exposed as the Ru(II) complexes in the other two mutants. 
 
 
Summary and conclusions 
  
Rapid phototriggered electron transfer from biotinylated guests to ruthenium photosensitizers which are covalently 
attached to cysteine residues of streptavidin is possible in carefully selected mutants. This is an important finding in 
view of photoredox catalysis which makes use of catalysts which are embedded in the protected environment of a 
biotin binding pocket of streptavidin and photosensitizers which are bound to the surface of streptavidin. Catalysts 
in the biotin binding pocket can exhibit markedly better performance than outside streptavidin,3a, 4b and our study 
paves the way to photoredox catalysis in specifically engineered artificial metalloenzymes.  
 
Acknowledgments 
 
This work was supported by the Swiss National Science Foundation as part of the NCCR Molecular Systems 
Engineering as well as the SNI (PhD scholarship awarded to Sascha Keller). 
 
Page 4 of 9Organic & Biomolecular Chemistry
5 
 
Table 1. Estimated through-space distances between -carbon atom of the targeted mutagenesis positions and the 
sulfur atom of a biotinylated cofactor based on the crystal structure of streptavidin (pdb code: 3PK2)15. The two 
closest C are listed as well as their mean values (Figure S16-S20 in the Supporting Information for details). 
 
mutant R1 [Å] R2 [Å] mean [Å] 
K121C 7.1 8.6 7.9 
S112C 6.9 12.1 9.5 
R84C 14.8 21.7 18.3 
T66C 17.8 22.1 20.0 
 
 
 
 
Figure 1. Chemical structures of the ruthenium(II)-label for streptavidin 1, the Biot-TAA moiety 2 (biotin is displayed 
in blue) and the TAA-Ac reference molecule 3. See Supporting Information for syntheses. 
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Figure 2. Surface display representation of homotetrameric streptavidin, highlighting the symmetry related positions 
selected for introducing cysteine residues: K121 (orange), S112 (yellow), R84 (blue), T66 (green) and biotin (red stick 
representation); (pdb code: 3PK2).15  
 
 
Figure 3. HABA displacement titrations of biotin (black symbols) and the biotinylated triarylamine Biot-TAA (red 
symbols) for a) WT streptavidin and b) K121C-Ru (see Supporting Information for experimental details). 
 
Figure 4. Illustration of the flash-quench procedure used for studying electron transfer in the Biot-TAA / Ru(II)-
streptavidin adducts.12 MV2+ stands for methylviologene. 
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Figure 5. (a) Transient absorption spectra of K121C-Ru measured after excitation at 532 nm with laser pulses of 10 
ns duration. The spectra were time-integrated over 200 ns immediately after excitation. Sample concentrations 
were: 50M Ru(II)-streptavidin, 120 mM MV2+, 25M Biot-TAA or TAA-Ac, where applicable. The solvent was MilliQ 
water at 25 °C. (b) Temporal evolution of the transient absorption signal at 760 nm for 3 of the 4 samples from (a). 
 
 
Table of contents figure.  
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